Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christine Asciutto"'
Autor:
Ellinor Östensson, Maria Silfverschiöld, Lennart Greiff, Christine Asciutto, Johan Wennerberg, Marie-Louise Lydrup, Ulf Håkansson, Pär Sparén, Christer Borgfeldt
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200554 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0179520.].
Externí odkaz:
https://doaj.org/article/6d334007d4634babadd9a6d8636b97bf
Autor:
Ellinor Östensson, Maria Silfverschiöld, Lennart Greiff, Christine Asciutto, Johan Wennerberg, Marie-Louise Lydrup, Ulf Håkansson, Pär Sparén, Christer Borgfeldt
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179520 (2017)
BACKGROUND:High-risk (HR) human papillomavirus (HPV) infection is an established cause of malignant disease. We used a societal perspective to estimate the cost of HR HPV-related cervical, vulvar, vaginal, anal, and penile precancer and cancer, and o
Externí odkaz:
https://doaj.org/article/ccabe4d0ae114d069b0c45812be5bc41
Autor:
Katrin Christine Asciutto, Avalon Ernstson, Jonas Norén, Christer Borgfeldt, Johan Sturesson, Ola Forslund
Publikováno v:
Anticancer Research. 39:381-386
BACKGROUND/AIM: Cervical cancer is associated with poorer diagnosis among the elderly and pap-smear screening has a lower sensitivity. Self-sampling for detection of high-risk human papillomavirus (hr-HPV) may be an alternative screening method. The
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Background During 2013 and 2016 the region of Skåne, Sweden started to analyse human papillomavirus (HPV) and cytology in postmenopausal women 60–65 years of age. Our aim was to evaluate high-risk (HR) HPV mRNA testing for the triage of HPV DNA-po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67114cbb5d61efba88d972824fc401c
https://doi.org/10.21203/rs.2.22222/v3
https://doi.org/10.21203/rs.2.22222/v3
Publikováno v:
In Vivo
Background/Aim: Vulva cancer surgery is associated with a high level of morbidity mostly due to wound healing disorders in the inguinal region following lymphadenectomy. Our aim is to evaluate the feasibility of negative pressure wound therapy (NPWT)
Background: During 2013 and 2016 the Region of Skåne, Sweden, started to analyse human papillomavirus (HPV) and cytology in postmenopausal women 60-65 years of age. Our aim was to evaluate if the presence of high-risk (HR) HPV mRNA could predict the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::725e39947e506d652700200e91ea229e
https://doi.org/10.21203/rs.2.22222/v1
https://doi.org/10.21203/rs.2.22222/v1
Autor:
Christer Borgfeldt, Pär Sparén, Christine Asciutto, Maria Silfverschiöld, Marie-Louise Lydrup, Johan Wennerberg, Ellinor Östensson, Lennart Greiff, Ulf Håkansson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 7, p e0200554 (2018)
PLoS ONE, Vol 13, Iss 7, p e0200554 (2018)
Background High-risk (HR) human papillomavirus (HPV) infection is an established cause of malignant disease. We used a societal perspective to estimate the cost of HR HPV-related cervical, vulvar, vaginal, anal, and penile precancer and cancer, and o
Publikováno v:
Anticancer research. 38(7)
Aim: To compare the clinical performance of human papillomavirus (HPV) mRNA and DNA assays in postmenopausal women. Materials and Methods: A total of 5,925 postmenopausal women were tested with cytology and the Luminex HPV DNA assay. High risk-HPV-po
Autor:
Lotten Darlin, Christer Borgfeldt, Katrin Christine Asciutto, Anna J. Henningsson, Henrik Borgfeldt
Publikováno v:
Anticancer research. 37(8)
Background/Aim: To compare human papillomavirus (HPV) DNA detection in self-collected vaginal and urine samples with clinician-taken cervical samples in relation to histology. Materials and Methods: Self-collected vaginal, urine and clinician-taken c
Autor:
Christine Asciutto, Lennart Greiff, Marie-Louise Lydrup, Christer Borgfeldt, Johan Wennerberg, Pär Sparén, Maria Silfverschiöld, Ulf Håkansson, Ellinor Östensson
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179520 (2017)
BACKGROUND:High-risk (HR) human papillomavirus (HPV) infection is an established cause of malignant disease. We used a societal perspective to estimate the cost of HR HPV-related cervical, vulvar, vaginal, anal, and penile precancer and cancer, and o